Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
DigitalOcean has pivoted from a developer-focused cloud to a cost-effective AI-native platform that is reeling in large enterprise inference commitments. Recent results and contract disclosures justify an upgrade to a tactical long: enter on a measured pullback, manage risk with a tight stop, and let the company’s contracted revenue and guidance ex…
Orion Energy Systems, Inc. reported a strong first quarter for fiscal 2027, with revenue increasing 32% year-over-year to $25.7 million, driven by growth across LED lighting, EV charging, and maintenance services. The company returned to profitability, achieving net income of $2 million and its seventh consecutive quarter of positive adjusted EBITD…
EyePoint, Inc. reports Q2 2026 financial results highlighting progress in its DURAVYU pivotal Phase 3 trials for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Topline data for wet AMD trials LUGANO and LUCIA are expected in August 2026 and Q4 2026 respectively, while pivotal DME trials COMO and CAPRI are fully enr…
The Brink's Company announced solid second-quarter 2026 results, highlighting 7% revenue growth driven by continued mid-teens organic growth in their AMS and DRS businesses. Net income rose 2%, while adjusted EBITDA increased 11%, and non-GAAP EPS grew 18%. The company reported record operating profit margins and free cash flow improvements. Regula…
AC Immune SA provided a first half 2026 update highlighting clinical advances in its wholly-owned programs targeting neurodegenerative diseases, notably Parkinson's and Alzheimer's. The Phase 2 trial of ACI-7104 in Parkinson’s disease progresses with full results expected in H2 2026, supported by a $4 million grant. The Alzheimer’s focused ACI-24 t…
Shopify announced strong financial results for Q2 2026, achieving a 34% year-over-year revenue increase, 30%+ growth in gross merchandise volume (GMV), gross profit, and free cash flow with margins reaching 18%. The company demonstrated broad-based growth across all merchant sizes and geographies, driven by the integration of AI and increased opera…
Crown Crafts, Inc., a US-based producer and distributor of infant and juvenile consumer products, will report its Q1 fiscal 2027 financial results on August 12, 2026, followed by a teleconference hosted by company executives. The company designs and markets a variety of infant and toddler products through its subsidiaries and sells to multiple reta…
President Vladimir Putin has named Denis Lyamin to head a new branch of the Russian military, the Unmanned Systems Forces, tasked with overseeing drone operations. The appointment comes as part of a wider reorganization announced mid-way through the fifth year of the war in Ukraine and includes changes to command of the Centre group and military lo…
Zimmer Biomet stock rose sharply in pre-market trading after the company posted second-quarter 2026 results that topped modest Street expectations. The report, combined with a recent high-profile analyst upgrade and positive results from sector peers, contributed to the move toward the $100 level and narrowed the gap to the 52-week high.
Eli Lilly stock climbed sharply in pre-market trading after the company reported second-quarter 2026 results that topped expectations and raised full-year revenue guidance. The report arrived as scheduled, the options market had priced in a sizable swing, and recent analyst action plus competitor results helped reinforce investor confidence.
Sasol forecasted headline earnings per share for fiscal 2026 of between R36 and R40, a 2% to 14% year-on-year rise that sits slightly under market consensus at the midpoint. The group also provided adjusted EBITDA guidance that exceeds analyst forecasts, even as an unrealised translation and derivatives loss and a stronger rand partially offset gai…
Flutter Entertainment announced its Q2 2026 financial results with 3% revenue growth driven by international markets and iGaming but reported a net loss of $296 million, significantly down from prior year profit. US revenue declined 6% led by sportsbook declines offset by strong iGaming growth. Adjusted EBITDA fell 45% overall, with US adjusted EBI…
Natural Resource Partners L.P. (NYSE: NRP) reported solid second quarter 2026 financial results, generating $41.7 million in free cash flow and declaring a $0.75 distribution per common unit for Q2. The company highlights progress toward debt repayment and plans to increase distributions by year-end. While mineral rights revenues improved due to hi…
A new Quaest poll, commissioned by brokerage Genial, shows President Luiz Inacio Lula da Silva maintaining a lead over Senator Flavio Bolsonaro ahead of October’s presidential vote. In a simulated second-round runoff Lula holds 44% support against Bolsonaro’s 39%, while a first-round projection places Lula at 39% and Bolsonaro at 30%. The survey in…
Eos Energy Enterprises saw its stock slide sharply in pre-market trading after reporting second-quarter 2026 results that showed a return to a per-share loss following a surprise profit in Q1. Although revenue matched previously announced preliminary figures and backlog remains robust, a confirmed gross margin loss of 69%–73%, sizeable dilution fro…
Flutter Entertainment plc announced that Dan Taylor will succeed Peter Jackson as Group CEO, effective October 1, 2026. Taylor currently leads Flutter's International division, contributing significantly to the group's revenue and EBITDA, and has played a crucial role in recent strategic acquisitions and FanDuel sportsbook improvements. The transit…
DaVita stock fell in pre-market trading after the company posted second-quarter results that beat consensus on both earnings and revenue but revealed weakening per-treatment economics. Management left full-year adjusted EPS guidance unchanged, and analysts remained cautious, driving the stock lower despite modest strength in treatment volumes.
Stride stock climbed sharply in pre-market trading after the online education company reported fiscal Q4 and full-year 2026 results that exceeded analyst forecasts on both revenue and adjusted earnings per share. Robust performance in the Career Learning segment, a company share repurchase, and reaffirmation of FY2028 targets helped soothe investor…
Freshpet stock climbed sharply in pre-market trading after the fresh pet food company reported second-quarter 2026 financial results ahead of the open. Results beat the low expectations that had left investors braced for a difficult quarter, while a recent analyst price-target increase and prior-quarter outperformance helped amplify the rally.
A severe heatwave gripping much of southern and eastern Europe has driven wildfires in Albania and Greece, prompted government appeals to cut power use in Hungary and raised red heat alerts in Italy. Firefighting teams have evacuated families and deployed ground and aerial assets to protect homes as agriculture and electricity systems face mounting…
Vishay Precision Group shares plunged in pre-market trading after the company reported second-quarter fiscal 2026 results that included a large GAAP earnings shortfall, a sequential decline in bookings and revenue guidance that missed Street expectations at the midpoint. While adjusted EPS slightly beat analyst consensus and revenue topped estimate…
Walt Disney Co. stock climbed sharply in pre-market trading after the company reported fiscal third-quarter 2026 results that beat expectations on adjusted earnings per share and outlined an expanded shareholder repurchase program aided by proceeds from the pending sale of its A+E stake. Leadership also announced a content-sharing arrangement with …
Eastman Kodak reported robust Q2 2026 results — including a return to GAAP net income, sharply higher gross profit and expanding margins — and filed its Form 10-Q and earnings release at 4:15 PM EDT on August 4. The report, followed by a conference call with CEO James Continenza and CFO David Bullwinkle, drove a 10.9% pre-open increase in the stock…
Eton Pharmaceuticals has acquired the U.S. rights to ASN-001, a late-stage topical product candidate targeting moderate infantile hemangiomas, complementing their existing oral treatment HEMANGEOL. ASN-001 showed promising Phase II/III results with significantly higher elimination rates compared to placebo and is expected to reach FDA submission by…
Jaguar Health Inc. saw its stock climb 10.0% in pre-market trading to $1.10 from a prior close of $1.00, with no company announcement identified to explain the move. Market participants point to technical relief in a deeply oversold micro-cap, speculative accumulation ahead of an expected August 13-14, 2026 earnings report, and recent share registr…
